Committed to babies and their health
Clinically proven to improve health outcomes of critically ill preemies
Committed to scientific and clinical research in breast milk
Prolact Product Safety
Available online ahead of print Beyond Necrotizing Enterocolitis: Other Clinical Advantages of an Exclusive Human Milk Diet

Beyond Necrotizing Enterocolitis: Other Clinical Advantages of an Exclusive Human Milk Diet

A reanalysis of two randomized controlled clinical trials evaluated the impact of an exclusive human milk diet on premature infants born weighing < 1250 grams (published by Sullivan et al and Cristofalo et al), found that an incorporation of cow milk-based products is correlated with an increase in parenteral nutrition and a longer time to achieve full feeds. Read the full article at Breastfeeding Medicine Magazine.

Why Choose Prolacta?

We are making the difference in the lives of premature infants.

Prolacta Bioscience, Inc. (Prolacta) is the pioneer in standardized human milk-based nutritional products for premature infants in the neonatal intensive care unit (NICU). Prolacta believes that there is no adequate replacement for human breast milk and, as such, we believe infant nutritional products should be human milk-based. As a privately held, for-profit and scientifically driven company, committed to improving premature infant nutrition, we are using human milk to change the standard of care in the NICU. Mothers who have a surplus of breast milk can help save the country’s most fragile infants by donating their extra breast milk through one of Prolacta’s affiliate milk banks.

Follow Us!